Retour
13
Également cotée sous
APNHF
OTC
Fourchette du Jour
7,50 €
8,86 €
Fourchette 52 Semaines
5,24 €
9,92 €
Volume
252
Moyenne 50J / 200J
7,60 €
/
6,43 €
Clôture Précédente
7,90 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,1 | 0,4 |
| P/B | 0,0 | 2,9 |
| ROE % | -1,3 | 3,7 |
| Net Margin % | -2,5 | 3,9 |
| Rev Growth 5Y % | 3,5 | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
14,54 €
12,53 € – 16,95 €
|
44 B | 1 |
| FY2027 |
13,46 €
11,60 € – 15,69 €
|
41 B | 1 |
| FY2026 |
11,84 €
10,20 € – 13,80 €
|
44 B | 1 |
Points Clés
Revenue grew 3,52% annually over 5 years — modest growth
Earnings declined -124,59% over the past year
Debt/Equity of 0,43 — conservative balance sheet
Generating 104,00M in free cash flow
PEG of 0,40 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,52%
Croissance
Revenue Growth (5Y)
3,52%
Revenue (1Y)-3,00%
Earnings (1Y)-124,59%
FCF Growth (3Y)-78,91%
Qualité
Return on Equity
-1,28%
ROIC0,89%
Net Margin-2,50%
Op. Margin3,31%
Sécurité
Debt / Equity
0,43
Current Ratio2,21
Interest Coverage0,87
Valorisation
P/E Ratio
-3,07
P/B Ratio0,04
EV/EBITDA22,99
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3,00% | Revenue Growth (3Y) | 3,21% |
| Earnings Growth (1Y) | -124,59% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3,52% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 43,36B | Net Income (TTM) | -1,08B |
| ROE | -1,28% | ROA | -0,80% |
| Gross Margin | 44,11% | Operating Margin | 3,31% |
| Net Margin | -2,50% | Free Cash Flow (TTM) | 104,00M |
| ROIC | 0,89% | FCF Growth (3Y) | -78,91% |
| Safety | |||
| Debt / Equity | 0,43 | Current Ratio | 2,21 |
| Interest Coverage | 0,87 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | -3,07 | P/B Ratio | 0,04 |
| P/S Ratio | 0,08 | PEG Ratio | 0,40 |
| EV/EBITDA | 22,99 | Dividend Yield | 0,03% |
| Market Cap | 3,33B | Enterprise Value | 33,04B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 43,36B | 44,71B | 40,71B | 38,61B | 37,77B |
| Net Income | -1,08B | 4,40B | 5,23B | 6,49B | 4,81B |
| EPS (Diluted) | -2,44 | 9,91 | 11,77 | 14,32 | 10,53 |
| Gross Profit | 19,13B | 19,42B | 18,41B | 18,31B | 17,79B |
| Operating Income | 1,44B | 7,00B | 7,82B | 8,67B | 7,07B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 135,89B | 139,16B | 134,28B | 111,38B | 109,68B |
| Total Liabilities | 51,00B | 54,29B | 48,05B | 40,43B | 44,06B |
| Shareholders' Equity | 84,89B | 84,86B | 86,24B | 70,94B | 65,63B |
| Total Debt | 36,12B | 36,46B | 29,28B | 22,25B | 24,87B |
| Cash & Equivalents | 6,41B | 12,34B | 10,91B | 6,18B | 8,55B |
| Current Assets | 38,70B | 44,09B | 44,50B | 34,56B | 32,71B |
| Current Liabilities | 17,50B | 24,38B | 23,15B | 23,40B | 36,75B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#772 of 820
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026